Currency & Language Dropdowns

Tesamorelin 10 mg

Price

590 kr

Buy 2
560.5 kr each
5% Off
Buy 5
531 kr each
10% Off
Buy 10
501.5 kr each
15% Off

Cart

Total 0 €

Research-grade peptide material supplied as lyophilized powder. Produced under controlled conditions and supported by batch-specific analytical documentation.

For Research Use Only. Not for human or veterinary use.

590 kr

Research-grade peptide material supplied as lyophilized powder. Produced under controlled conditions and supported by batch-specific analytical documentation.

For Research Use Only. Not for human or veterinary use.

Description

Product Overview

Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analogue supplied for laboratory research use only.
Published scientific literature has investigated Tesamorelin in relation to GHRH receptor biology, growth hormone physiology, endocrine signaling and metabolic research models.

Technical Specifications

  • Product Name: Tesamorelin
  • Product Type: Synthetic GHRH Analogue
  • Amount: 10 mg
  • Form: Lyophilized Powder
  • Purity: ≥99%
  • Storage: 2–8°C
  • Batch Testing: Batch-Specific COA Available
  • Intended Use: Research Use Only

Batch Verification

Each batch is linked to a batch-specific Certificate of Analysis (COA).
Available documentation may include purity testing, identity verification, and batch-related analytical data.

Selected Scientific References

Falutz J, Allas S, Mamputu JC, Potvin D, Kotler D, Somero M, et al.
Metabolic effects of a growth hormone-releasing factor in patients with HIV.
New England Journal of Medicine. 2007;357(23):2359–2370.
PMID: 18057338
DOI: 10.1056/NEJMoa072375

Falutz J, Mamputu JC, Potvin D, Moyle G, Soulban G, Loughrey H, et al.
Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in human immunodeficiency virus-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials with safety extension data.
Journal of Clinical Endocrinology & Metabolism. 2010;95(9):4291–4304.
PMID: 20554713
DOI: 10.1210/jc.2010-0490

Stanley TL, Feldpausch MN, Oh J, Branch KL, Lee H, Torriani M, et al.
Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation: a randomized clinical trial.
JAMA. 2014;312(4):380–389.
PMID: 25038357
DOI: 10.1001/jama.2014.8334

Dhillon S.
Tesamorelin: a review of its use in the management of HIV-associated lipodystrophy.
Drugs. 2011;71(8):1071–1091.
PMID: 21668043
DOI: 10.2165/11202240-000000000-00000

Research Profile

  • Product Name: Tesamorelin
  • Product Type: Synthetic GHRH Analogue
  • Amount: 10 mg
  • Form: Lyophilized Powder
  • Purity: ≥99%
  • Storage: 2–8°C
  • Batch Testing: Batch-Specific COA Available
  • Intended Use: Research Use Only

Scope of Use

This product is supplied strictly for laboratory research purposes.
It is not intended for human use, veterinary use, diagnostic applications, or therapeutic and clinical applications.
True Peptides does not provide dosing guidance, administration instructions, or usage recommendations.

RESEARCH PROFILE

Product Name
Tesamorelin
Amount
10 mg
Form
Lyophilized Powder
Purity
≥99%
Storage
2–8°C
Batch testing
Batch-Specific COA Available
Intended Use
Research Use Only

WHY TRUE PEPTIDES?

EXPLORE ADVANCED RESEARCH PEPTIDES

Precision-focused peptides backed by transparency, research integrity and batch-specific verification.

SLU-PP-332 10 mg

SLU-PP-332 5 mg

VIP 10 mg

LL-37 5 mg

PT-141 10 mg

LOT/BATCH

Epithalon 50 mg – Batch Documentation

Batch Information

Product Name: 10-Amino-1MQ 50 mg
LOT Number: 240710A
Expiration Date: July 18, 2028 
Storage Conditions: 2–8 °C, unless otherwise specified
Use Category: Research Use Only 

Certificate of Analysis

The Certificate of Analysis (COA) for this batch is available below.

Analytical Documentation

This batch is linked to analytical documentation intended to support traceability and laboratory recordkeeping.

The COA may include:

• batch identification
• analytical purity results
• identity verification
• method reference information 

Batch Verification Notice

This page applies only to the lot number listed above.

Documentation shown here is batch-specific and should not be used as a reference for other lots or product versions. 

Research Use Only

This material is supplied strictly for laboratory research purposes.

It is not intended for:

• human use
• veterinary use
• diagnostic applications
• therapeutic or clinical applications

True Peptides does not provide dosing guidance, administration instructions, or usage recommendations.

Longevity meets Science

Documentation Transparency

All analytical data provided is batch-specific and linked to the corresponding product.

Transparency in documentation allows for:

  • Verification of analytical results
  • Improved reproducibility in research environments
  • Clear traceability between supply and usage

True Peptides prioritizes accessible and verifiable documentation as a core part of its quality framework.

Storage & Stability Considerations

Peptide materials are supplied as lyophilized powders.

Recommended storage: 2–8°C refrigerated, unless otherwise specified.

Proper storage conditions are required to maintain material integrity. Stability may vary depending on peptide structure and environmental exposure.

Handling should be performed within controlled laboratory conditions.